These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comment on:Kadomoto, S. et al. "Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis" Zins K; Abraham D Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32028699 [TBL] [Abstract][Full Text] [Related]
3. CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis. Tan J; Xu T; Gou Y; Wang H; Liang Z; Cao Y; Wang H; Yu Y; Jiao N; Zhang Z Stem Cell Res Ther; 2022 Jul; 13(1):294. PubMed ID: 35841069 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis. Liu W; Wang W; Wang X; Xu C; Zhang N; Di W Cancer Lett; 2020 Mar; 472():59-69. PubMed ID: 31866467 [TBL] [Abstract][Full Text] [Related]
5. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis. Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732 [TBL] [Abstract][Full Text] [Related]
6. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages. Li Q; Laumonnier Y; Syrovets T; Simmet T Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234 [TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer. Liu B; Jia Y; Ma J; Wu S; Jiang H; Cao Y; Sun X; Yin X; Yan S; Shang M; Mao A Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1067-1074. PubMed ID: 27797715 [TBL] [Abstract][Full Text] [Related]
8. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer. Han G; Wu D; Yang Y; Li Z; Zhang J; Li C Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596 [TBL] [Abstract][Full Text] [Related]
9. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992 [TBL] [Abstract][Full Text] [Related]
10. Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition. Liu J; Zheng X; Deng H; Xu B; Chen L; Wang Q; Zhou Q; Zhang D; Wu C; Jiang J Oncotarget; 2017 Dec; 8(70):115244-115253. PubMed ID: 29383156 [TBL] [Abstract][Full Text] [Related]
11. Macrophages promote growth, migration and epithelial-mesenchymal transition of renal cell carcinoma by regulating GSDMD/IL-1β axis. Xie D; Mao Y; Du N; Ji H; Li J Cytokine; 2022 Nov; 159():156021. PubMed ID: 36057231 [TBL] [Abstract][Full Text] [Related]
12. Reply to Comment on "Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis" Cancers 2020 12, 89. Kadomoto S; Izumi K; Hiratsuka K; Nakano T; Naito R; Makino T; Iwamoto H; Yaegashi H; Shigehara K; Kadono Y; Nakata H; Saito Y; Nakagawa-Goto K; Mizokami A Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033135 [TBL] [Abstract][Full Text] [Related]
13. The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis. Liu W; Wang W; Zhang N; Di W Onco Targets Ther; 2020; 13():12739-12750. PubMed ID: 33335408 [TBL] [Abstract][Full Text] [Related]
14. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer. Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142 [TBL] [Abstract][Full Text] [Related]
15. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110 [TBL] [Abstract][Full Text] [Related]
16. Malignant phenotype of renal cell carcinoma cells is switched by ukrain administration in vitro. Gagliano N; Pettinari L; Aureli M; Martinelli C; Colombo E; Costa F; Carminati R; Volpari T; Colombo G; Milzani A; Dalle-Donne I; Gioia M Anticancer Drugs; 2011 Sep; 22(8):749-62. PubMed ID: 21799470 [TBL] [Abstract][Full Text] [Related]
17. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. Hou KZ; Fu ZQ; Gong H World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462 [TBL] [Abstract][Full Text] [Related]
18. CCR6 He H; Wu J; Zang M; Wang W; Chang X; Chen X; Wang R; Wu Z; Wang L; Wang D; Lu F; Sun Z; Qu C Am J Cancer Res; 2017; 7(5):1151-1163. PubMed ID: 28560063 [TBL] [Abstract][Full Text] [Related]
19. CCL20/CCR6 Mediated Macrophage Activation and Polarization Can Promote Adenoid Epithelial Inflammation in Adenoid Hypertrophy. Ye C; Guo X; Wu J; Wang M; Ding H; Ren X J Inflamm Res; 2022; 15():6843-6855. PubMed ID: 36583131 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma]. Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]